PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer
Clinical trial NCT04174339 · UNKNOWN
Trial details
- NCT number
- NCT04174339
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2020-12-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.